MedPath

Comparison of the Effectiveness of Virtual Reality Exposure Therapy with Eye Movement Desensitization and Reprocessing Therapy on Symptoms of Acrophobia and Anxiety Sensitivity

Not Applicable
Conditions
Fear of Heights or Acrophobia.
Acrophobia
F40.241
Registration Number
IRCT20210213050343N1
Lead Sponsor
Persian Gulf University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
45
Inclusion Criteria

A score greater than or equal to 50 in the Acrophobia Questionnaire
fulfillment of all specific phobia diagnostic criteria (eg, acrophobia) based on SCID-5
submission of written consent for participation in the study by participants and their parents
Age 14 to 18 years

Exclusion Criteria

patients with hearing or visual impairment such as stereoscopy blindness or nystagmus
presence of any other mental disorders as assessed using the structured clinical interview
presence of specific physiological illnesses such as heart, lung and respiratory diseases, epilepsy and seizures
developmental or intellectual disability, cognitive impairment, known balance disorders such as vertigo, dependent on alcohol or drugs
other current psychological treatment

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Acrophobia: Severe anxiety when standing in high places or watching other people in such situations causes severe fear in people with a phobia. As in other fears, one is fully aware of the irrationality and irrationality of one's fears but nevertheless cannot overcome them. These people try to avoid facing such situations, so that avoidance may have a negative impact on their personal or social life.Anxiety Sensitivity: It is a structure of individual differences in which the individual is afraid of the physical symptoms associated with anxiety arousal (increased heart rate, shortness of breath, dizziness) and basically arises from the belief that these symptoms have potentially harmful consequences. Social, cognitive, and physical leads. Timepoint: One week before the intervention and one week after the last intervention session. Method of measurement: Acrophobia Questionnaire and Anxiety Sensitivity Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath